Protective Factors Against Elderly Suicide (ProFAES)

Methodical Search of Protective Factors During Interview of Suicidal Elderly Patients: Effect on the Proposed Care

Suicidal intentionality is generally stronger among the elderly, suicidal acts are more violent and are combined with a greater physical fragility. The suicide of an older adult is a situation that often leads to helplessness feelings.

Analysis of the literature reveals two types of major interventions in order to reduce suicide rate: reducing risk factors and increasing protective factors. Risk factors are well documented, particularly from studies using psychological autopsies. However, protective factors are much less studied for the elderly. Yet the identification of relevant and available protective mechanisms in a suicidal crisis is essential to effectively guide nurses and health professionals in therapeutic commitment and intervention.

Study Overview

Status

Terminated

Detailed Description

France has a suicide rate (16.2 per 100 000 inhabitants) well above the European average rate (10.2 per 100 000 inhabitants). The Poitou-Charentes region is in a situation of excess mortality by suicide compared to France (+ 25%). While the ratio of suicide attempts per suicide is about 200/1 before 25 years, it is estimated to be 4/1 after 65 years, or even 1/1 in elderly men. In France, suicide attempts are not systematically recorded and the frequency of suicidal ideation is poorly understood. The consensus conference on suicidal crisis highlights a number of clinical points specific to the elderly population (suicidal ideas are not always clearly expressed or unidentified, there are various manifestations of the psychic crisis, greater vulnerability of this population), but the complexity of interactions between suicidal risk factors limits our predictive capabilities of suicidal intention in an elderly person. Analysis of the literature reveals two types of major interventions in order to reduce the suicide rate: those aimed at reducing risk factors and those aimed at increasing protective factors. The objective of our research is to determine the effect of protective factor methodical search on post-crisis patient care.

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • La Rochelle, France
        • Groupe Hospitalier de la Rochelle Ré Aunis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients will be screened in the psychiatric, geriatric and emergency departments of la Rochelle and Rochefort secondary hospitals

Description

Inclusion Criteria:

  • Attempted suicide and / or suicidal ideas
  • Informed and agreed to participate

Exclusion Criteria:

  • Cognitive disorders
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Suicide attempt or ideas
Elderly patients who attempted suicide or who emitted suicidal ideas
Protective factor exploration during post-suicidal crisis interview

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of outpatients (with a low to moderate risk of suicidal recurrence)
Time Frame: 7 days
Based on risk, emergency and hazard, patients are classified as being at low, moderate and high risk of suicidal recurrence. Patients with low to moderate risk of suicidal recurrence are either inpatient or outpatient.
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients considering themselves to be in good health
Time Frame: 7 days
Score > 0 at Health Status questionnaire (SF36) item 1
7 days
Number of patients considering that their physical or mental state did not alter their social life
Time Frame: 7 days
Score > 50 at Health Status questionnaire (SF36) items 6 or 10
7 days
Number of patients maintaining autonomy
Time Frame: 7 days
Score = 0 at Instrumental Activities of Daily Living scale
7 days
Number of patients with religious practice
Time Frame: 7 days
Binary answer from patients (yes/no I have a religious practice)
7 days
Number of patients with a sense of success and self-esteem
Time Frame: 7 days
Binary answer from patients (yes/no I have a a sense of success and self-esteem)
7 days
Number of patients considering their family environment to be satisfactory
Time Frame: 7 days
Binary answer from patients (yes/no I am satisfied with my family environment)
7 days
Number of patients with at least one environmental protection factor
Time Frame: 7 days
Friendly network, associative investment, volunteering, specialized care, recreation, positive image from the entourage, presence of a third party, housekeeper, postman, pet, shopping facilities, doctor, pharmacy ...
7 days
Number of patients with social protection factors
Time Frame: 7 days
Easy access to Health facilities, sufficient financial income
7 days
Number of patients able to adapt to difficult situations
Time Frame: 7 days
score ≤ 12 at Neo Personality Inventory vulnerability item
7 days
Number of patients with extraversion capabilities
Time Frame: 7 days
score ≥ 20 at Neo Personality Inventory extraversion item
7 days
Number of patients with openness to others
Time Frame: 7 days
score ≥ 20 at Neo Personality Inventory Openness to feelings item
7 days
Number of patients considering that their health has improved
Time Frame: 3 months
Patients will be asked if they feel that their health has improved, has not changed or has worsened
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Karine REISS, MD, Groupe Hospitalier de la Rochelle Ré Aunis

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2018

Primary Completion (Actual)

February 16, 2019

Study Completion (Actual)

May 27, 2019

Study Registration Dates

First Submitted

May 19, 2017

First Submitted That Met QC Criteria

May 19, 2017

First Posted (Actual)

May 22, 2017

Study Record Updates

Last Update Posted (Actual)

July 5, 2019

Last Update Submitted That Met QC Criteria

July 2, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2015/P08/079

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Study Data/Documents

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide, Attempted

Clinical Trials on Post-suicidal crisis interview

3
Subscribe